2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences
XTalks
DECEMBER 24, 2020
Most antibody drugs and vaccines have been developed to target parts of the spike protein. Drug Approvals. So far, the FDA has approved a handful of drugs for the treatment of COVID-19. These include remdesivir, baricitinib, dexamethasone and three antibody drugs.
111 
Let's personalize your content